HRP20110610T1 - Ms postupci za procjenjivanje glikana - Google Patents
Ms postupci za procjenjivanje glikana Download PDFInfo
- Publication number
- HRP20110610T1 HRP20110610T1 HR20110610T HRP20110610T HRP20110610T1 HR P20110610 T1 HRP20110610 T1 HR P20110610T1 HR 20110610 T HR20110610 T HR 20110610T HR P20110610 T HRP20110610 T HR P20110610T HR P20110610 T1 HRP20110610 T1 HR P20110610T1
- Authority
- HR
- Croatia
- Prior art keywords
- glycans
- glycan
- mass
- ratio
- similar
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract 20
- 239000000203 mixture Substances 0.000 claims abstract 14
- 150000004676 glycans Chemical class 0.000 claims 24
- 150000002632 lipids Chemical class 0.000 claims 2
- 239000000463 material Substances 0.000 claims 2
- 108090000765 processed proteins & peptides Proteins 0.000 claims 2
- 108090000623 proteins and genes Proteins 0.000 claims 2
- 102000004169 proteins and genes Human genes 0.000 claims 2
- 210000001519 tissue Anatomy 0.000 claims 2
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 claims 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 claims 1
- 229930186217 Glycolipid Natural products 0.000 claims 1
- 102000003886 Glycoproteins Human genes 0.000 claims 1
- 108090000288 Glycoproteins Proteins 0.000 claims 1
- 102000016611 Proteoglycans Human genes 0.000 claims 1
- 108010067787 Proteoglycans Proteins 0.000 claims 1
- 230000002902 bimodal effect Effects 0.000 claims 1
- 210000001124 body fluid Anatomy 0.000 claims 1
- 239000010839 body fluid Substances 0.000 claims 1
- 150000001720 carbohydrates Chemical class 0.000 claims 1
- 235000014633 carbohydrates Nutrition 0.000 claims 1
- 210000004027 cell Anatomy 0.000 claims 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 claims 1
- 235000013399 edible fruits Nutrition 0.000 claims 1
- 210000002744 extracellular matrix Anatomy 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 230000003834 intracellular effect Effects 0.000 claims 1
- 150000002772 monosaccharides Chemical class 0.000 claims 1
- 210000002381 plasma Anatomy 0.000 claims 1
- 229920001282 polysaccharide Polymers 0.000 claims 1
- 239000005017 polysaccharide Substances 0.000 claims 1
- 210000003296 saliva Anatomy 0.000 claims 1
- 210000000582 semen Anatomy 0.000 claims 1
- 210000002966 serum Anatomy 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
- 210000002700 urine Anatomy 0.000 claims 1
- 235000013311 vegetables Nutrition 0.000 claims 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6848—Methods of protein analysis involving mass spectrometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/66—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood sugars, e.g. galactose
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/24—Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/25—Chemistry: analytical and immunological testing including sample preparation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Computational Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Diabetes (AREA)
- Tropical Medicine & Parasitology (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US92367707P | 2007-04-16 | 2007-04-16 | |
| PCT/US2008/060334 WO2008128221A1 (en) | 2007-04-16 | 2008-04-15 | Ms methods to evaluate glycans |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20110610T1 true HRP20110610T1 (hr) | 2011-10-31 |
Family
ID=39615678
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20110610T HRP20110610T1 (hr) | 2007-04-16 | 2011-08-18 | Ms postupci za procjenjivanje glikana |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US8043863B2 (sl) |
| EP (1) | EP2135091B1 (sl) |
| JP (1) | JP5116837B2 (sl) |
| AT (1) | ATE512366T1 (sl) |
| AU (1) | AU2008240074B2 (sl) |
| CA (1) | CA2682750A1 (sl) |
| CY (1) | CY1111811T1 (sl) |
| DK (1) | DK2135091T3 (sl) |
| ES (1) | ES2367210T3 (sl) |
| HR (1) | HRP20110610T1 (sl) |
| PL (1) | PL2135091T3 (sl) |
| PT (1) | PT2135091E (sl) |
| SI (1) | SI2135091T1 (sl) |
| WO (1) | WO2008128221A1 (sl) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT2135091E (pt) | 2007-04-16 | 2011-09-01 | Momenta Pharmaceuticals Inc | Métodos de ms para avaliar glicanos |
| EP2702077A2 (en) | 2011-04-27 | 2014-03-05 | AbbVie Inc. | Methods for controlling the galactosylation profile of recombinantly-expressed proteins |
| US9505833B2 (en) | 2012-04-20 | 2016-11-29 | Abbvie Inc. | Human antibodies that bind human TNF-alpha and methods of preparing the same |
| WO2013158279A1 (en) | 2012-04-20 | 2013-10-24 | Abbvie Inc. | Protein purification methods to reduce acidic species |
| US9181572B2 (en) | 2012-04-20 | 2015-11-10 | Abbvie, Inc. | Methods to modulate lysine variant distribution |
| US9067990B2 (en) | 2013-03-14 | 2015-06-30 | Abbvie, Inc. | Protein purification using displacement chromatography |
| ES2975188T3 (es) | 2012-07-26 | 2024-07-03 | Momenta Pharmaceuticals Inc | Glicoproteínas con propiedades antiinflamatorias |
| US9512214B2 (en) | 2012-09-02 | 2016-12-06 | Abbvie, Inc. | Methods to control protein heterogeneity |
| US9217168B2 (en) | 2013-03-14 | 2015-12-22 | Momenta Pharmaceuticals, Inc. | Methods of cell culture |
| WO2014151878A2 (en) | 2013-03-14 | 2014-09-25 | Abbvie Inc. | Methods for modulating protein glycosylation profiles of recombinant protein therapeutics using monosaccharides and oligosacharides |
| US9017687B1 (en) | 2013-10-18 | 2015-04-28 | Abbvie, Inc. | Low acidic species compositions and methods for producing and using the same using displacement chromatography |
| US8956830B2 (en) | 2013-03-14 | 2015-02-17 | Momenta Pharmaceuticals, Inc. | Methods of cell culture |
| US20160108450A1 (en) | 2013-05-02 | 2016-04-21 | Momenta Pharmaceutcals, Inc. | Sialylated glycoproteins |
| US10464996B2 (en) | 2013-05-13 | 2019-11-05 | Momenta Pharmaceuticals, Inc. | Methods for the treatment of neurodegeneration |
| US9598667B2 (en) | 2013-10-04 | 2017-03-21 | Abbvie Inc. | Use of metal ions for modulation of protein glycosylation profiles of recombinant proteins |
| EP3058084A4 (en) | 2013-10-16 | 2017-07-05 | Momenta Pharmaceuticals, Inc. | Sialylated glycoproteins |
| US9181337B2 (en) | 2013-10-18 | 2015-11-10 | Abbvie, Inc. | Modulated lysine variant species compositions and methods for producing and using the same |
| US9085618B2 (en) | 2013-10-18 | 2015-07-21 | Abbvie, Inc. | Low acidic species compositions and methods for producing and using the same |
| US20150139988A1 (en) | 2013-11-15 | 2015-05-21 | Abbvie, Inc. | Glycoengineered binding protein compositions |
| JP6471606B2 (ja) | 2015-02-23 | 2019-02-20 | Ａｇｃ株式会社 | 積層体の剥離装置及び剥離方法並びに電子デバイスの製造方法 |
| WO2017117218A1 (en) | 2015-12-30 | 2017-07-06 | Momenta Pharmaceuticals, Inc. | Methods related to biologics |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3383587B2 (ja) * | 1998-07-07 | 2003-03-04 | 株式会社東芝 | 静止画像連続情報記録方法と光ディスクと光ディスクの情報再生装置と情報再生方法 |
| EP1518120A4 (en) * | 2002-03-11 | 2008-08-13 | Momenta Pharmaceuticals Inc | ANALYSIS OF SULFATE POLYSACCHARIDES |
| EP1587408A4 (en) * | 2002-12-20 | 2007-09-05 | Momenta Pharmaceuticals Inc | GLYCAN MARKER FOR DIAGNOSIS AND MONITORING OF DISEASES |
| WO2005009039A2 (en) * | 2003-07-03 | 2005-01-27 | Waters Investments Limited | System and method for isotopic signature and mass analysis |
| US7138228B2 (en) * | 2003-09-05 | 2006-11-21 | Regents Of The University Of California | Protein O-sulfonation |
| US20060057638A1 (en) * | 2004-04-15 | 2006-03-16 | Massachusetts Institute Of Technology | Methods and products related to the improved analysis of carbohydrates |
| EP1775581A4 (en) * | 2004-08-04 | 2009-06-03 | Eisai R&D Man Co Ltd | INVESTIGATION OF A PEPTIDE-BASED AMINO ACID SEQUENCE DEPENDING ON THE ISOTOPE RATIO |
| JP2006047239A (ja) * | 2004-08-09 | 2006-02-16 | National Institute Of Advanced Industrial & Technology | 硫酸化単糖の同定方法及び硫酸化単糖異性体混合物の分析方法 |
| US20090114809A1 (en) | 2005-09-02 | 2009-05-07 | Australian Nuclear Science & Technology Organisation | Isotope ratio mass spectrometer and methods for determining isotope ratios |
| PT2135091E (pt) | 2007-04-16 | 2011-09-01 | Momenta Pharmaceuticals Inc | Métodos de ms para avaliar glicanos |
-
2008
- 2008-04-15 PT PT08745856T patent/PT2135091E/pt unknown
- 2008-04-15 US US12/595,894 patent/US8043863B2/en active Active
- 2008-04-15 AT AT08745856T patent/ATE512366T1/de active
- 2008-04-15 AU AU2008240074A patent/AU2008240074B2/en not_active Expired - Fee Related
- 2008-04-15 EP EP08745856A patent/EP2135091B1/en active Active
- 2008-04-15 WO PCT/US2008/060334 patent/WO2008128221A1/en active Application Filing
- 2008-04-15 SI SI200830367T patent/SI2135091T1/sl unknown
- 2008-04-15 ES ES08745856T patent/ES2367210T3/es active Active
- 2008-04-15 CA CA002682750A patent/CA2682750A1/en not_active Abandoned
- 2008-04-15 JP JP2010504184A patent/JP5116837B2/ja active Active
- 2008-04-15 PL PL08745856T patent/PL2135091T3/pl unknown
- 2008-04-15 DK DK08745856.8T patent/DK2135091T3/da active
-
2011
- 2011-08-18 HR HR20110610T patent/HRP20110610T1/hr unknown
- 2011-09-08 CY CY20111100864T patent/CY1111811T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2010525327A (ja) | 2010-07-22 |
| EP2135091B1 (en) | 2011-06-08 |
| CY1111811T1 (el) | 2015-10-07 |
| AU2008240074B2 (en) | 2013-02-21 |
| ES2367210T3 (es) | 2011-10-31 |
| DK2135091T3 (da) | 2011-09-19 |
| PL2135091T3 (pl) | 2011-11-30 |
| EP2135091A1 (en) | 2009-12-23 |
| US8043863B2 (en) | 2011-10-25 |
| ATE512366T1 (de) | 2011-06-15 |
| JP5116837B2 (ja) | 2013-01-09 |
| PT2135091E (pt) | 2011-09-01 |
| AU2008240074A1 (en) | 2008-10-23 |
| SI2135091T1 (sl) | 2011-10-28 |
| US20100133430A1 (en) | 2010-06-03 |
| CA2682750A1 (en) | 2008-10-23 |
| WO2008128221A1 (en) | 2008-10-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20110610T1 (hr) | Ms postupci za procjenjivanje glikana | |
| JP2010525327A5 (sl) | ||
| Curtis et al. | p38 mitogen-activated protein kinase targets the production of proinflammatory endothelial microparticles | |
| Holderness et al. | Polysaccharides isolated from Acai fruit induce innate immune responses | |
| Vida et al. | Role of macrophages in age-related oxidative stress and lipofuscin accumulation in mice | |
| Wang et al. | Ginger polysaccharides induced cell cycle arrest and apoptosis in human hepatocellular carcinoma HepG2 cells | |
| Kwon et al. | Porphyran induces apoptosis related signal pathway in AGS gastric cancer cell lines | |
| Park et al. | The differential effect of high and low molecular weight fucoidans on the severity of collagen‐induced arthritis in mice | |
| Calabrò et al. | Triggering of suicidal erythrocyte death following boswellic acid exposure | |
| de Andrade Luz et al. | Cytotoxicity of the coagulant Moringa oleifera lectin (cMoL) to B16-F10 melanoma cells | |
| Zhao et al. | Improving the activity of Lycium barbarum polysaccharide on sub-health mice | |
| Jegham et al. | A novel aminosteroid of the 5α-androstane-3α, 17β-diol family induces cell cycle arrest and apoptosis in human promyelocytic leukemia HL-60 cells | |
| Luzak et al. | Extract from Ribes nigrum leaves in vitro activates nitric oxide synthase (eNOS) and increases CD39 expression in human endothelial cells | |
| Veach et al. | Anti-platelet and anti-thrombogenic effects of shikimic acid in sedentary population | |
| Gnanamangai et al. | Analysis of antioxidants and nutritional assessment of date palm fruits | |
| Paulose et al. | Effect of grape seed extract on the bond strength and durability of resin-dentin interface | |
| Reboleira et al. | Brown seaweeds | |
| Mohan et al. | Anticancer potential of Tinospora cordifolia and arabinogalactan against benzo (a) pyrene induced pulmonary tumorigenesis: a study in relevance to various biomarkers | |
| Krichen et al. | Sulfated polysaccharides from Tunisian fish skins: Antioxidant, DNA damage protective effect and antihypertensive activities | |
| CN102660615B (zh) | 一种抗氧化肽及其制备方法 | |
| Phongpradist et al. | The in vitro effects of black soldier fly larvae (Hermitia illucens) oil as a high-functional active ingredient for inhibiting hyaluronidase, anti-oxidation benefits, whitening, and UVB protection | |
| Yang et al. | In vitro and in vivo immuno-enhancing effect of fucoidan isolated from non-edible brown seaweed Sargassum thunbergii | |
| Olas et al. | Effects of polyphenol-rich extract from berries of Aronia melanocarpa on the markers of oxidative stress and blood platelet activation | |
| Kuntz et al. | Extracts from Brassica oleracea L. convar. acephala var. sabellica inhibit TNF-α stimulated neutrophil adhesion in vitro under flow conditions | |
| Rodrigues et al. | In vitro inhibition of thrombin generation by sulfated polysaccharides from the tropical red seaweed Gracilaria birdiae Plastino & Oliveira/Inibição in vitro da geração de trombina por polissacarídeos sulfatados da alga marinha vermelha tropical Gracilaria birdiae Plastino & Oliveira |